|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 31/56 | |||
| A61K 31/573 |
| (11) | Number of the document | 1937210 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06826056.1 |
| Date of filing the European patent application | 2006-10-17 | |
| (97) | Date of publication of the European application | 2008-07-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/040429 |
| Date | 2006-10-17 |
| (87) | Number | WO 2007/047607 |
| Date | 2007-04-26 |
| (30) | Number | Date | Country code |
| 728209 P | 2005-10-18 | US |
| (72) |
EDELMAN, Jeffrey, L., US
HARRISON, Kelly, M., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRATING POSTERIOR SEGMENT TISSUES |
| OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRATING POSTERIOR SEGMENT TISSUES |